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Abstract
Embryonic stem cells (ESCs) have the ability to form aggregates, which are called embryoid bodies (EBs). EBs
mimic early embryonic development and are commonly produced for cardiomyogenesis. Here, we describe a
method of EB formation in hydrodynamic conditions using a slow-turning lateral vessel (STLV) bioreactor and
the subsequent differentiation of EBs into cardiomyocytes. EBs formed in the STLV were compared with con-
ventional techniques, such as hanging drop (HD) or static suspension cell culture (SSC), for homogeneity of EB
size, shape, proliferation, apoptosis, and in vitro cardiac differentiation. After 3 days of culture, a four-fold
improvement in the yield of EB formation/mL, a six-fold enhancement in total yield of EB/mL, and a nearly 10-
fold reduction of cells that failed to incorporate into EBs were achieved in STLV versus SSC. During cardiac
differentiation, a 1.5- to 4.2-fold increase in the area of cardiac troponin T (cTnT) per single EB in STLV versus
SSC and HD was achieved. These results demonstrate that the STLV method improves the quality and quantity
of ES cells to form EBs and enhances the efficiency of cardiac differentiation. We have demonstrated that the
mechanical method of cell differentiation creates different microenvironments for the cells and thus influences
their lineage commitments, even when genetic origin and the culture medium are the same. Ascorbic acid
(ASC) improved further cardiac commitment in differentiation assays. Hence, this culture system is suitable for
the production of large numbers of cells for clinical cell replacement therapies and industrial drug testing
applications.
Introduction
Cell transplantation is an emerging field for patientssuffering from severe heart failure (White and Claycomb,
2003). Cardiac cell transplantation, including cardiomyocyte
cell lines (Messina et al., 2004), fetal cardiomyocytes (Gon-
zales et al., 2012), skeletal myocytes (Reinecke and Murry,
2000; Invernici et al., 2008), and bone marrow–derived stem
cells (Barile et al., 2011), has successfully engrafted into the
adult heart. However, a limiting factor for development of cell
therapy is the inadequate number of donor cells obtained that
are needed for curing cardiovascular disease. Due to ethical
reasons, use of cardiomyoplasty for treating heart failure is
not possible (Penn and Mal, 2006).
Up to now, embryonic stem cells (ESCs) have been the
most promising cell sources for cardiovascular cell therapy,
because ESCs are capable of spontaneously differentiating
into cardiomyocytes (Mummery et al., 2007). The spontane-
ously contracting cellular structures within the developing
embryoid bodies (EBs) (containing myocytes) also have
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structural and functional properties similar to that of early-
stage cardiac tissue (Kehat et al., 2001; Snir et al., 2003).
Furthermore, transplantation of ESC-derived cardiomyo-
cytes into rat myocardial infarctions leads to the formation of
stable cardiomyocyte grafts and attenuation of the re-
modeling process resulting in improved cardiac function
(Caspi et al., 2007; Laflamme et al., 2007). Hence, ESCs are a
promising source for cell-based therapies in humans, in-
cluding cardiac tissue engineering.
Even though ESCs have been shown by numerous re-
search groups to be capable of differentiating into cardio-
myocytes in mice and humans, the overall efficiency and the
quantity of cells obtained by differentiation of ESCs is still
rather low (Boheler et al., 2002; Mummery et al., 2003). Dif-
ferentiation of ESCs into cardiomyocytes usually requires an
initial aggregation step that results in the formation of
spherical cell clusters referred to as EBs, which recapitulate
several aspects of the developing embryo, including, similar
to gastrulation in vivo, differentiation into cells representative
of the endoderm, mesoderm, and ectoderm lineages (Des-
baillets et al., 2000; Hopfl et al., 2004). The hanging drop
method (HD) permits a certain level of control over EB size;
however, these cultures are inherently incapable of large-
scale EB production. Whereas suspension static culture (SSC)
has the advantage of being easily scalable and requires less
expertise, it often results in agglomeration of EBs into ir-
regularly shaped large masses as well causing extensive cell
death (Dang et al., 2002; Chen et al., 2011). Hence, the in-
dustrial application of these methods is restricted due to their
complications and difficult manageability (Kurosawa, 2007).
Recent development of novel bioreactors for large-scale
production of ES-derived cells applying cell expansion, dif-
ferentiation, or tissue formation on biomaterial scaffolds
offer a tight control of the in vitro environment, including the
exchange of nutrients, oxygen, and metabolites (Rungar-
unlert et al., 2009). Stirred suspension cultures (e.g., spinner
flasks) have disadvantages due to the generation of shear
forces, which may damage the EB cells (Chisti, 2001; He
et al., 2012). Another type of bioreactor, the slow-turning
lateral vessel (STLV), is characterized by EB spatial immo-
bility with an extremely low fluid shear stress and oxygen-
ation by diffusion. The STLV has been described to improve
efficiency of EB formation and stem cell differentiation into
the cells of the three germ layers. The STLV bioreactor pro-
duces EBs that are uniform in size, without necrotic centers,
and with higher yields (a nearly four-fold increase in the
number of EB particles in comparison to SSC with human
cells) (Gerecht-Nir et al., 2004). To date, the influence of the
dynamic culture parameters (i.e., time of EB adherence to
gelatin-coated dishes, cell seeding density, etc.) has been
reported to affect cardiac differentiation from ESCs (Run-
garunlert et al., 2011). However, there is inadequate infor-
mation concerning the histological characteristics of EBs,
which could vary due to differences in cell seeding density
and day of culture formed when using the STLV. Regardless
of these advances, there are still some challenges that must
be addressed before this technique could be considered safe,
such as improved culture conditions to obtain specific cells,
including cardiomyocytes.
Moreover, many researchers have found that cytokines,
growth factors, and some synthetic chemical compounds can
improve cardiomyogenic differentiation rates in vitro. Syn-
thetic chemicals have a particular advantage, due to longer
active half-life within solutions. Hence, these chemicals are
stable in in vitro cell culture over several days, or even weeks
(Heng et al., 2004). Ascorbic acid (ASC), one such synthetic
chemical compound (vitamin C), has been described to
promote ESC cardiomyogenic differentiation. In ESCs, in-
creased expression of cardiac genes, including GATA-
binding protein 4 (GATA4), a-myosin heavy chain (MHC),
and b-MHC in a developmentally controlled manner have
been reported when using ASC (Takahashi et al., 2003).
To develop a larger-scale culture of ES-derived cells for
cardiac differentiation, we used a bioprocess that directs EB
formation in a scalable, fully controlled STLV following in-
oculation with a mouse ES single-cell suspension. EBs gen-
erated by use of the optimized STLV bioreactor were
compared to SSC and HD methods for efficiency in gener-
ating EBs and subsequent cardiac differentiation. Moreover,
we investigated the effect of ASC supplement on cardio-
myocyte differentiation. The STLV method was found to
create a more homogeneous and uniform EB population that
is favorable for subsequent cardiomyocyte formation, com-
pared with ‘‘traditional’’ SSC and HD methods.
Materials And Methods
Materials and general culture
Culture reagents were purchased from Invitrogen Life
Technologies (Carlsbad, CA, USA), and all chemicals were
purchased from Sigma-Aldrich (St Louis, MO, USA) unless
otherwise specified. Cell cultured was performed at 37C in a
humidified atmosphere containing 5% CO2. Medium was
changed daily on mouse ESC cultures and every 2 days
during differentiation.
Mouse ESCs and culture conditions
Parental ESCs (Hprt-deficient mouse ESC line HM1; 129Sv/
Ola genetic background) (Magin et al., 1992) were cultured on
mitomycin C–inactivated confluent mouse embryonic fibro-
blast (MEF) feeder layers, which were obtained from 13.5-day
postcoitus mouse embryos (Nagy et al., 2006a,b). These cells
were maintained in ES medium consisting of Dulbecco’s
modified Eagle medium (DMEM-Glutamax-I), 15% (vol/vol)
fetal bovine serum (FBS; Sera Laboratories International, West
Sussex, UK) supplemented with 1000U/mL mouse leukemia
inhibitory factor (LIF; ESGRO, Chemicon International),
0.1mM b-mercaptoethanol (b-ME), 0.1mM nonessential ami-
no acids (NEAA), and, 50lg/mL streptomycin, 50U/mL
penicillin. ESCs were cultured on feeder layers for at least two
passages after thawing and prior to the differentiation pro-
cedure, and the cells were cultured for at least one passage in
feeder-free conditions on gelatin-coated plates with LIF
(2,000U/ml) in the ES medium. Cells were passaged every 1–
2 days prior to reaching 70% confluency.
EB formation
Three different methods were used for EB formation:
STLV bioreactor (RCCS-4H with 110mL of vessels, Synthe-
con, Cellon S.A. Bereldange, Luxembourg), the SSC method,
and the HD method. For each method, the ESCs were dis-
sociated with 0.05% trypsin–EDTA solution to form a single-
cell suspension.
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In the first study, we have evaluated the initial cell seeding
density and time in culture effects on morphology and size of
EBs in STLV and HD culture systems and on their subse-
quent differentiation into cardiomyocytes (Fig. 1). Two dif-
ferent cell amounts were used in STLV method: 3 · 105 and
5 · 105 cells/mL (STLV1 and STLV2, respectively) in 110mL
of differentiation medium. The rotation speed was 10 rota-
tions per minute (rpm). For the HD method, 800 cells in 20lL
of differentiation medium (ES culturing medium without
LIF) were pipetted on the inside surface of a bacterial Petri
dish lid. To prevent drying of the cell droplets, the Petri dish
bottom was filled with phosphate-buffered saline (PBS). The
cells were forced to aggregate with the help of gravity by
reversing the Petri dish lid. Two days later, the EBs were
transferred onto poly(2-hydroxyethyl methacrylate) (poly-
HEMA)–treated 100-mm bacteriological Petri dishes.
In the second study, the effects of different culture systems
(STLV, SSC, and HD) on morphology and size of EBs and
their subsequent differentiation into cardiomyocytes were
evaluated (Fig. 2). The STLV and SSC cultures were started
with an equal quantity of cells (the optimized cell seeding
density derived from the first study; 3 · 105 cells/mL) and
HD-derived EBs were formed using 800 cells per drop
(4 · 104 cells/mL) (Fig. 2). For the SSC, 55mL of cell sus-
pension (cell seeding density, 3· 105 cells/mL) was cultured
on a poly-HEMA–treated 150-mm bacteriological Petri dish
(351058, BD Falcon, California, USA). All EBs were kept for
up to 3 days in the same culture without interruption, except
for the sample collection.
In vitro cardiac differentiation assay
Individual EBs were placed in differentiation medium into
wells of a 24-well plate containing 0.1% gelatin-coated cov-
erslips at different time points (day 2 to day 5; D2–D5). The
EBs were then cultured further, with a medium change every
second day, for a period of 14 or 21 days. Beating activities
were recorded daily under a phase-contrast microscope.
Morphometric analysis
To assess the efficiency of the EB formation, 10mL of
STLV and 5mL of SSC culture medium were passed through
a 100-lm cell strainer to separate individual cells from cell
aggregates constituting EBs. The EBs were then transferred
into Petri dishes and observed by inverted light microscopy.
To investigate the total EB number for each group, the EBs
present in 1mL of STLV and SSC culture medium were
counted as the yield of EB production/mL. The individual
cells that passed through the cell strainer were counted as the
total free cells/mL. After that, the EBs were dissociated with
a 0.25% trypsin–EDTA solution to form a suspension of
single cells and counted as the total cells of EBs/mL. The
FIG. 1. Schematic presentation of in vitro differentiation procedure of ESCs into cardiomyocytes in STLV and HD culture
systems using ESCs derived from different initial cell seeding densities: 3 · 105 and 5 · 105 cells/mL (STLV1 and STLV2,
respectively) and time in culture (days 2–5).
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average diameter of EBs was calculated by measuring both
the small and large diameters of 40 representative EBs per
each replicates. The results represent the mean– standard
error of the mean (SEM) of triplicate independent experi-
ments. An Olympus IX 71 inverted microscope with an
Olympus DP70 digital camera (Olympus GmbH, Germany)
was used daily for phase-contrast imaging of EBs. ImageJ
image analysis software (http://rsb.info.nih.gov/ij) was ap-
plied to measure the cross-sectional area of EBs.
Histological analyses
EBs were collected, washed three times in PBS, then fixed
with 4% paraformaldehyde (PFA) for 15min, embedded in
paraffin, and examined for general histological analysis. Se-
rial sections were generated and 4-lm-thick sections were
Hematoxylin & Eosin (H&E) stained for morphology as-
sessment, with the proliferation marker Ki-67 (RM-9106, di-
luted 1:200; Thermo Scientific, USA) and with the apoptosis
marker cleaved caspase-3 (Asp 175, 9661, diluted 1:200; Cell
Signaling Technology, USA). Furthermore, the sections were
stained for Oct4 (pluripotency marker, sc9081, diluted 1:100;
Santa Cruz Biotechnology, USA), Brachyury (mesoderm
marker, ab20680, diluted 1:200; Abcam, UK), Pax6 (ectoderm
marker, diluted 1:200; Developmental Studies Hybridoma
Bank, Iowa City, IA, USA), and a-fetoprotein (AFP, endo-
derm marker, ab3969, diluted 1:100; Abcam, UK).
Quantification of beating activity of EBs
In the first experiment, the effect of the initial cell seeding
density and day of EB transfer to gelatin on the efficiency of
cardiac differentiation was investigated as shown in Figure 1.
Individual EBs derived from each group—3 · 105 and 5 · 105
cells/mL (STLV1andSTLV2, respectively) and4· 104 cells/mL
(HD) as control—were placed on D2, D3, D4, and D5 into
individual wells of 24-well plates (BD Biosciences, Mis-
sissauga, Canada, http://www.bdbiosciences.ca) in 1mL of
spontaneous differentiation medium. In the second study,
the effect of EB culture conditions (STLV, SSC, and HD) and
ASC supplement on the efficiency of cardiac differentiation
was investigated as shown in Figure 2. Individual EBs de-
rived from each group were placed on D3 into wells of a 24-
well plates in 1mL of spontaneous differentiation medium
(without ASC supplement) or in 1mL of induced differen-
tiation medium (with ASC supplement). The EBs were then
cultured further for 14 or 21 days. The beating activities were
recorded daily with a Nikon TMS inverted light microscope
(Nikon Instruments, Melville, NY, USA), and the quantity of
EBs beating spontaneously was counted. Forty-eight EBs
derived from each group and each replicate were observed,
and the number of beating EBs was presented as the rate of
the total plated EBs. The cardiac beatings were further
evaluated by grading of cardiac beating (beating rate and the
area of cardiac beating) as described earlier (Rungarunlert
et al., 2011). The results are presented as the mean – SEM of
three independent experiments.
Immunofluorescent staining
After investigating the efficiency of cardiac beating the
EBs were stained for cardiac troponin-T (cTnT) to measure
the area of cTnT as described earlier (Rungarunlert et al.,
2011). The selected EB samples were analyzed by a ‘‘double-
blind’’ approach to avoid biases (eight EBs per one replica-
tion), and the experiments were completed in triplicates. EBs
FIG. 2. Schematic presentation of in vitro differentiation procedure of ESCs into cardiomyocytes in different culture systems
(STLV, SSC, and HD culture).
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were plated onto 0.1% gelatin-coated coverslips and fixed
with 4% PFA for 15min at room temperature, followed by
permeabilization with 0.25% Triton-X100 for 10min. After
blocking with 1% bovine serum albumin (BSA) in PBS, the
samples were incubated with the primary antibodies: Mouse
monoclonal against cTnT (ab33589, diluted 1:200; Abcam,
UK) and Oct4 (sc9081, diluted 1:100; Santa Cruz Bio-
technology, USA) overnight at 4C. Following washing, the
samples were labeled with AlexaFluor 594 goat anti-mouse
immunoglobulin G (IgG)-conjugated secondary antibody
(A11005, diluted 1:2000; Invitrogen Life Technologies, USA)
and AlexaFluor 488 goat anti-rabbit IgG (A11008, diluted
1:2000; Invitrogen Life Technologies, USA) at room temper-
ature for 60min. Vectashield mounting medium including
4¢,6-diamidino-2-phenylindole (DAPI; Vector Laboratories)
was used to counterstain the nuclei. EBs were imaged with a
Carl Zeiss Microscope (Carl Zeiss MicroImaging GmbH,
Germany), and the area of cTnT was measured using Digital
Image Processing Software (AxioVision4.8.1, Carl Zeiss Mi-
croImaging GmbH, Germany).
RT-PCR and quantitative real-time PCR (qRT-PCR)
analysis
Following the manufacturer’s protocol, total RNA was
isolated using the RNeasy Mini Kit (Qiagen, Hilden, Ger-
many) and treated with RQ1 RNase-free DNase (Promega,
Madison, WI, USA). For each sample, RNA was reverse
transcribed using the SuperScript III Reverse Transcriptase
(Invitrogen Life Technologies, USA), using oligo (dT)12–18
primer and 10mM PCR-grade dNTP mixture (Invitrogen).
For the quantitative PCR (qPCR) reaction, SYBR Green
JumpStart Taq ReadyMix (Sigma-Aldrich) was used, and
samples were run on a Qiagen Rotor-Gene Q controlled by
Rotor-Gene Q Software. PCR reactions were performed
using 5· Green GoTaq Flexi Buffer, MgCl2 solution, GoTaq
Pol (all from Promega, Madison, WI, USA), and dNTP Mix,
PCR Grade (Invitrogen). Gapdh was applied as reference
gene in the study. The primers and reaction conditions for
the PCR reactions are presented in Table 1. The mean – SEM
results of three independent experiments are presented.
Statistical analysis
The data from at least three independently performed
experiments are presented as mean – SEM. SPSS Statistics
version 18.0 was used for all statistical analyses. One-way
analysis of variance (ANOVA) was used to compare the size
of the EBs, the percentage of EBs beating, the grading of EB
beating, and the area of cTnT between groups. The yield of
EB production/mL, the total cells of EBs/mL, and the total
free cells/mL between the two groups was analyzed by in-
dividual Student t-tests. Values with p< 0.05 were considered
statistically significant.
Results
Effect of initial cell seeding density and time in culture,
on morphology, and size of EBs in STLV and HD
culture systems
In the current study, STLV cultures were initiated using
two different numbers of cells (3· 105 and 5· 105 cells/mL),
and EBs derived from HD (HD-EBs) were formed using 800
cells per drop (4· 104 cells/mL) (Fig. 1). We have previously
determined that 3· 105 (STLV1) or 5· 105 (STLV2) cells/mL
initial seeding density and 10 rpm gives the optimal EB
number and yield in STLV conditions (Rungarunlert et al.,
2011). By D2, cultures formed spherical EBs with a regular
shape and uniform size. EB size increased over time and
showed similar gross morphology (458.1– 6.89, 510.3– 7.27,
513.8– 7.48, and 580.3– 8.49lm diameter from STLV1 and
462.8– 7.07, 511.6– 8.69, 535.6– 10.51, and 547.8– 9.70lm di-
ameter from STLV2 for D2, D3, D4, and D5 respectively (Fig.
3A, B). HD-EBs grew modestly on D2 (299.2– 4.94lm) and D3
(377.6– 5.58 lm); however, their growth accelerated by D4
(510.4– 10.49lm) and D5 (624.9– 11.97lm). Furthermore,
HD-EBs, which appeared homogeneous in size on D2 and D3,
Table 1. Properties of the Oligonucleotide Primers Used in qRT-PCR Reactions
Primer Size (bp) Sequence
Oct-4 110 (Forward) 5’-AGCCGACAACAATGAGAACC-3’
(Reverse) 5’-TCTCCAGACTCCACCTCACA-3’
Brachyury 161 (Forward) 5’-TACACCTCTAATGTCCTCCCTTG-3’
(Reverse) 5’-CCATACAGTTGACTTCCCAACAC-3’
Nkx2.5 74 (Forward) 5’-ACACCCACGCCTTTCTCAGT-3’
(Reverse) 5’-AGGTCCCCAGACGCCA-3’
Tnnt2 117 (Forward) 5’-CGGATCAATGACAACCAGA-3’
(Reverse) 5’-GGGCAAGGACACAAGCAG-3’
Myh6 80 (Forward) 5’-CTACGCCTTCGTCTCTCAGG-3’
(Reverse) 5’-AGGCACTATCAGTGGCCAAG-3’
Myl2 90 (Forward) 5’- TGACCTAAGGGACACATTTGC-3’
(Reverse) 5’-ATTGGACCTGGAGCCTCTTT-3’
a-fetoprotein 129 (Forward) 5’-AACAAGGAGGAGTGCTTCCA-3’
(Reverse) 5’-GGTTGTTGCCTGGAGGTTT-3’
GAPDH 79 (Forward) 5’-AATGTGTCCGTCGTGGATCT-3’
(Reverse) 5’-CCTGCTTCACCACCTTCTTG-3’
Nkx2.5, NK2 transcription factor related, locus 5; Tnnt2, troponin T type 2 (cardiac); Myh6, myosin, heavy chain 6, cardiac muscle, alpha;
Mly2, myosin regulatory light chain 2, ventricular/cardiac muscle isoform.
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became more heterogeneous at later time points (by D4 and
D5). This resulted in extensive EB agglomeration, which led to
the formation of large EBs (Fig. 3A; red arrows) between D3
and D5. The STLV in contrast, produced homogeneous-sized
EBs, even on D4 and D5, at both cell seeding densities.
Effect of initial cell seeding density and length
of culture period on proliferation and apoptosis
in the STLV and HD culture systems
To elucidate the macroscopic structure of EBs derived
from different initial cell seeding densities and length of
FIG. 3. Dynamic formation of EBs derived from different cell seeding densities and time in culture in both the STLV and HD
culture systems. (A) Gross morphology of EBs. (B) Size of EBs. (C) Histological section of EB formation (H&E, Ki-67, and
Caspase 3). Data presented as mean – SEM of three independent experiments. The difference was considered significant when
p < 0.0001 (****). Scale bars represent (A) 500 lm and (C) 100lm. Color images available online at www.liebertpub.com/cell
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culture period in both the STLV and HD methods, cell
morphology, proliferation, and apoptosis assays were per-
formed. At D2, STLV1-EBs and STLV2-EBs were larger and
more irregular than HD-EBs. By D3, D4, and D5, EBs from all
groups were larger in both size and density (black spot ap-
peared in the EB centers). However, HD-EBs began to ag-
glomerate after D2 (observed as spotted areas within the EB
center) (Fig. 3A, red arrow, and Fig. 3C, black arrow). In
contrast, both STLV-EBs (STLV1-EBs and STLV2-EBs) did
not appear to agglomerate. By D4, HD-EBs began to display
cystic structures and by D5, at least one cyst have been ob-
served in more than 50% of HD-EBs (Fig. 3C, blue arrow).
Ki67 was used to stain proliferating cells in EBs during
differentiation. Higher levels of proliferating cells were
FIG. 4. Cardiac differentiation potential of EBs derived from different cell seeding densities and time of EB plating, on
cardiac differentiation using the STLV and HD culture method. (A–C) Percentage of contracting cardiomyocytes in out-
growth of attached EBs: observed on D7 (A–D), observed on D8 (E–H), observed on D9 (I–L). Observed on D10 (M–P). Data
presented as mean – SEM of three independent experiments. The difference was considered significant when p < 0.05 (*),
<0.01 (**), <0.005 (***), <0.0001 (****).
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detected at D2 and D3 (Fig. 3C). Proliferation was less ex-
tensive at D4 and D5, and no differences were noted between
the different cell seeding densities of the STLV-derived EBs
(Fig. 3C). Slightly higher levels of positive Ki67 cells were
found in the STLV-EBs compared to the HD-EBs, regardless
of the day of culturing time. Importantly, a clear outer layer
of proliferating cells became obvious in STLV-EBs from D4.
Cleaved caspase-3 staining was performed to detect apo-
ptotic cells and revealed slight differences between STLV1
and STLV2 groups at the same time points (Fig. 3C). STLV2
started to form dense cores of apoptotic cells within EBs
earlier than STLV1. In addition, a dense inner core of apo-
ptotic cells was visible within STLV-EBs after long-term
culturing (D4 and D5) (Fig. 3C). In HD-EBs sparser staining
of cleaved caspase-3 was observed at D2 and D3, constitut-
ing less of the total EB area, but small, dense multiple cores
of apoptotic cells were visible at D4 and D5. These data in-
dicate that long-term culturing of EBs appears to reduce cell
viability in all groups, likely due to a higher number of cells
with programmed cell death.
By comparing serial sections of corresponding STLV-EBs, a
proliferating outer and an apoptotic inner layer (presumably
forming a cavity at a later time point) was clearly visible. On
HD-EB sections, a clear outer and inner layer was absent.
Cell seeding density and day of EB transfer to gelatin
influencing the efficiency of cardiac differentiation
Both in STLV and HD groups, an in vitro cardiac differen-
tiation assay was used to compare EBs produced by the two
different cell seeding densities and the day of transferring EBs
onto gelatin plate. STLV1-EBs plated on D2 and D3 and STLV
2-EBs plated on D2 started to form rhythmically contracting
areas earlier (on D7) (Fig. 4A, B) than the other groups, which
started to form rhythmically contracting areas only on D8
(Fig. 4E, F). All STLV1-EBs plated on D2 and D3 were beating
by days 9 and 10, respectively (100%) (Fig. 4I, M). STLV2-EBs
plated on D2 were all beating by day 10 (100%) (Fig. 4N), and
those plated on D3 and D4 were all beating slightly later, i.e.,
day 14 (Fig. S1B) (Supplementary Data are available at
www.liebertpub.com/cell/). When comparing the percentage
of beating from different cell seeding densities, STLV1-EBs
performed significantly higher than the STLV2-EBs on day 8
of cardiac differentiation (STLV1, D2–D5, 58– 10.1, 86– 9.2%,
18– 3.5%, and 1– 0.7% vs. STLV2, D2–D5, 25– 5.5%, 35– 12%,
6– 2.3%, and 0%) as shown in Figure 4E, F, and H. In addi-
tion, EBs plated on earlier days (D2 and D3) performed sig-
nificantly higher than EBs plated at later time points (D4 and
D5) in both culture systems (STLVs and HD) (Fig. 4A–C, E–G,
I–K). Even though, HD-EBs showed earlier spontaneous
beating than the STLV-EBs (on D6) (data not shown), at later
time points, not all EBs were beating (Fig. 4C, G, K, and O and
Fig. S1C). Together, these results suggested that the STLV-1
EBs transferred and plated on D2 and D3 were likely the most
optimal scenario for in vitro cardiac differentiation.
Although, all groups were capable of committing to car-
diomyogenesis, the area and the frequency of beating dif-
fered. Therefore, the beating was graded and evaluated (Fig.
S1E; Rungarunlert et al., 2011). EBs plated on D2 and D3
showed the fastest beating over their entire surface area
(grade 4). When comparing the two different cell seeding
densities, STLV1-EBs plated on D2 and D3 beat across the
entire area and faster (grade 4) (even more than in the STLV-
2 EBs). Furthermore, HD-EBs plated on D2–D5 exhibited a
similar grading pattern as the STLV-EBs.
Finally, the areas of cTnT were measured (Fig. 5A–E) to
estimate the efficacy of cardiac differentiation. STLV1-EBs
produced significantly more cTnT than STLV2-EBs during
in vitro cardiac differentiation, when STLV1-EBs and STLV2-
EBs were plated on D2 and D3 (Fig. 5A, B). In addition, cTnT
was expressed more centrally in the STLV1-EBs and at the
edges of attached EBs and formed a filamentous network (Fig.
5F). When comparing the day of transfer of EBs onto gelatin,
STLV1-EBs plated on D3 expressed significantly more cTnT
than those plated on D2, D4, and D5 (Fig. 5E). EBs plated on
D4 and D5 showed a more central cTnT distribution and rarely
at the edges of the EBs with no filamentous connections. Ad-
ditionally, STLV-EBs formed particularly more filamentous
cTnT networks than the HD-EBs, which expressed cTnTmostly
in the centers with no filamentous connections (Fig. 5F). A
summary of these results reveals that EBs derived from STLV
cultures and plated on D3 onto gelatin-coated dishes gave a
higher percentage of contracting area per EB, a higher grading
of beating, and higher levels of cardiac cTnT expression than
the conventional HD-produced EBs. Also, the percentage of
beating areas in EBs plated on D2 and D3 were higher then in
those plated only on D4 or D5. Overall, the best condition is
plating EBs on D3 or earlier. This observation shows the critical
importance of optimizing the day of plating of the EBs onto
gelatinized dishes. The following experiments were designed
on the basis of the results of this initial study, indicating that
STLV1 conditions are appropriate for producing more EBs,
with a large and more homogeneous size and uniform shape.
Efficiency of EB formation, morphology, and size using
different culture systems
To examine the effect of different culture conditions on EB
development, three culture systems, including, STLV, SSC,
and HD were compared. HD-derived EBs were generated
using 800 cells per drop (4· 104 cells/mL) whereas the SSC
and STLV systems were both initiated with 3 · 105 cells/mL
(Fig. 2). All EBs were kept for a period of maximum 3 days in
the same culture without interruption, except for the sample
collection. Cell aggregates started to form 1 day earlier in the
SSC cultures compared to the STLV culture at 36 h. However,
agglomeration of SSC-EBs also appeared on the second day
(at 48 h), which was not observed in the STLV-EBs (Fig. 6A).
SSC-EBs formed less defined cell aggregates, which were
irregular in shape. EBs started to form at 24 h in the HD;
however, three to four EBs formed in each drop. One EB per
one drop appeared only at 48 h. As expected, on the basis of
gross morphology, D3 STLV-EBs and HD-EBs exhibited the
most homogeneous appearance: EBs were uniform, rounded,
symmetric, and only a few cell agglomerations were ob-
served (Fig. 6A). On D3, EBs had an average diameter of
518.1 – 10.2 lm for the STLV-EBs, and the HD-EBs were
slightly smaller, with an average size of 405 – 5.2 lm. In
contrast, SSC-EBs were heterogeneous and formed dumbbell
shapes with an average small diameter of 443.2– 19.4 lm and
average large diameter of 607.9– 32.7 (Fig. 6A). On the basis
of these findings, we could conclude that the STLV culture
system was more effective in producing homogeneous EBs
than the SSC culture system. Even though the HD culture
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system could produce homogeneous EBs similar to that in
the STLV system, the HD method remains insufficient for
mass EB production.
A four-fold improvement of EB production using the
STLV culture system was significantly observed in compar-
ison to static conditions (174– 5.3 and 41– 10.4 EBs/mL, re-
spectively) (Fig. S2A). Also, a six-fold enhancement in total
cell yield of EB/mL was significantly achieved (39 – 2.1 · 105
and 7 – 1.4 · 105 cells/mL, respectively) (Fig. S2B). Further-
more, a nearly 10-fold diminishment in total cell yield of free
cells, which were not incorporated into EBs, was significantly
observed compared to the SSC method (6 – 1.1 · 105 and
55– 6.4 · 105 cells/mL) (Fig. S2C). The average cell density of
single EBs obtained in STLV and SSC was similar on D3
(4.2 · 104– 0.98 cells/EB and 4.2 · 104 – 1.98 cells/EB),
whereas the average cell density of a single EB derived by
FIG. 5. Cardiac differentiation potential of EBs derived from different cell seeding densities and time of EB plating, on
cardiac differentiation in both the STLV and HD culture method. (A–E) Area of cTnT per EBs (· 105lm2). (F) EBs im-
munolabeled with cTnT (red). Data are presented as mean – SEM of three independent experiments. The difference was
considered significant when p< 0.01 (**), < 0.005 (***), < 0.0001 (****). Scale bars, 200 lm. Color images available online at
www.liebertpub.com/cell
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HD on D3 was smaller (2.5 · 104 – 0.7 cells/EB). On the basis
of these findings, our data indicated that the STLV system is
efficient at producing a large scale of EBs, when compared to
the SSC culture system.
Effect of EB culture conditions on proliferation,
apoptosis, and pluripotency, including marker
expression during differentiation
Because the histology and structure of EBs derived from
different culture systems is not well known, we examined the
EB formation process at daily intervals for up to 8 days on
histological sections. Data indicated that the central apoptotic
area was most extensive in the STLV cultures and that prolif-
eration is localized to the outer layers of EBs, which surround
the apoptotic inner core. Both Ki67 and cleaved caspase-3
staining of EB sections revealed that proliferation and apo-
ptosis was less intense and more sparse in the core of the HD-
EBs compared to the STLV- or SSC-derived EBs (Fig. 6B).
When assessing the pluripotency marker (Oct4), there was
no difference in Oct4 staining between the different culture
methods, which disappeared by D3. In the case of the germ
layer marker, Brachyury, the STLV-EBs and HD-EBs showed
high intense staining in comparison to the SSC-EBs. In the
case of AFP, staining was abundant in the center of the SSC-
EBs but remained sporadic in both the STLV-EBs and HD-
EBs. Pax6 expression was only observed in a few cells in the
core all of the EBs, which corresponds to the expected
staining of D3 EBs, where only a few ectoderm cells are likely
present (Fig. 6B).
FIG. 6. Dynamic formation and the efficiency rate of EBs derived from different culture systems (STLV, SSC, and HD). (A)
Gross morphology of EBs. (B) Histological section of EB formation (H&E, Ki-67, Caspase 3, Oct 4, Brachyury, Pax6, and AFP).
Color images available online at www.liebertpub.com/cell
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Influence of EB culture conditions and ASC
supplement on the efficiency of cardiac differentiation
The results from the cardiac differentiation studies
are shown in Figure 7, A–F. HD-EBs formed a signifi-
cantly higher percentage of rhythmically contracting ar-
eas compared to STLV-EBs and SSC-EBs on D7 (Fig. 7A).
However, HD-EBs formed a similar percentage of rhyth-
mically contracting areas compared to STLV-EBs on D8
(Fig. 7B). Moreover, HD-EBs did not reach 100% beating
efficiency by D9–D17, unlike the STLV-EBs (Fig. 7C).
Additionally, culturing EBs with ASC supplement im-
proved the rate of cardiac differentiation (Fig. 7A, B). A
grading system has been used to evaluate the cardiac
beating based on the rate of the beating and the size of
the beating area (Fig. 7F). STLV-EBs had larger beating
areas, and the beating was fast (grade 4). The addition of
ASC to aid in inducing cardiac differentiation also in-
creased the beating areas and rates, regardless of the
culture method used.
FIG. 7. Cardiac differentiation potential of EBs derived from different culture systems (STLV, SSC, and HD). (A–E) Per-
centage of contracting cardiomyocytes in outgrowths of attached EBs, when EBs were cultured in medium with or without
ASC supplement. (F) Cardiac beating activity was evaluated by grading the area of beating foci and the beating rate. Data
presented as mean – SEM of three independent experiments. The difference was considered significant when p< 0.05 (*), < 0.01
(**), < 0.0001 (****).
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To further evaluate the EB ability to form cardiac out-
growths amongst the different culture conditions, all EBs
outgrowths were immunostained with the cardiac lineage
commitment marker cTnT. Our results demonstrated that
STLV-EBs were superior for producing larger areas of cTnT
expression at day 14 (1.5–4.2 times higher than SSC-EBs and
HD-EBs; Fig. 8A), regardless of the culture medium used.
Moreover, STLV-EBs showed a higher distribution of fila-
mentous cTnT within the central area and edges of the EBs
compared to the other groups at the same time point (Fig.
8B). The expression of cTnT within SSC-EBs and HD-EBs
was lower (Fig. 8B). The distribution of cTnT within the SSC-
EBs and HD-EBs was predominantly in the center of the EB
and rarely at the edges of the EB, with no filamentous con-
nections observed (Fig. 8B). Furthermore, ASC supplemen-
tation increased the expression area of cTnT per EB in all
groups (1.9 times in STLV, 3.7 times in SSC, and 2.3 times in
HD group).
Influence of EB culture conditions and ASC
supplement on gene expression during cardiac
differentiation
Finally, cardiac-specific gene expression of cardiac out-
growths was examined by qRT-PCR (Fig. 9) using RNA ex-
tracted from STLV-, SSC-, and HD-derived EBs at D3, D7,
D14, and D21 of culture, supplemented with or without ASC.
Gene expression of pluripotency (Oct-4; Fig. 9A), early me-
soderm (Brachyury-T; Fig. 9B), early (Nkx2.5; Fig, 9C), and
late (Tnnt2, Myh6, and Myl2; Fig. 7D–7F, respectively) cardiac
markers were assayed. Moreover, AFP (which is an endoderm
differentiation marker) was also investigated (Fig. 9G).
In undifferentiated cells, the level of Oct-4 was high then
decreased to very low levels in all EBs by D7 (Fig. 9A). In
parallel, upregulation of cardiac marker genes, namely,
Nkx2.5, Tnnt2, Myh6, and Myl2 (Fig. 9C–F, respectively), has
been observed. Expression of Brachyury was high at the be-
ginning (D3–D7; Fig 9B) and showed a marked reduction later
on, as expected. However, Brachyury mRNA was expressed
only inHD-EBs, regardless of whether theywere culturedwith
or without ASC. In the other groups, Brachyury levels declined
gradually without any peak. This observation indicates that in
the STLV-EBs and SSC-EBs all of the cells have been differen-
tiating toward different lineages (e.g., cardiac), and there was a
lack of cell subpopulations to enter the primitive streak stage.
The amount ofNkx2.5 transcripts (early cardiac precursor)was
upregulated by D7 in all groups. STLV-EBs showed a higher
expression of Nkx2.5 mRNA than the other EBs by D7 when
cultured without ASC supplement and showed the highest
expression of Nkx2.5 mRNA compared to the other EBs (15·
induction), when cultured with ASC supplement. This indi-
cated that STLV-EBs and ASC supplement induced cardiac
differentiation by increasing Nkx2.5 mRNA (Fig. 9C).
As the cardiac differentiation progressed, a change toward
the dominance of cardiomyocyte structural markers was
observed, including upregulation of Tnnt2, Myh6, and Myl2
(Fig. 9D–F) peaking on D14 and with downregulation by
D21 in all groups. The late cardiac marker Tnnt2 was, as
expected, practically absent initially (D3) and strongly in-
duced later. No statistical difference of Tnnt2 mRNA ex-
pression was observed between the groups (Fig. 9D). Even
though no pattern of Myh6 and Myl2 mRNA expression was
revealed between the different culture methods or different
culture medium, STLV-EBs showed the highest expression of
Myh6 mRNA compared to the other EBs, when cultured
with ASC supplement. Interestingly, cultured HD-EBs pre-
ferred to differentiate into endodermal cells rather than car-
diac cells, as AFP mRNA was highly expressed in HD-EBs
(3–6 times vs. other groups and 3000–12,000 times vs. ESCs),
when cultured with ASC supplement (Fig. 9G).
These data confirmed that STLV-derived EBs can differ-
entiate efficiently toward terminal cardiac lineage commit-
ment. Furthermore, our results strongly suggest that the
culture condition method used affects the expression of
many cardiac markers. ASC supplement also appears to
improve both early and late cardiac muscle formation, es-
pecially when EBs are cultured in the STLV system.
Discussion
Differentiation of EBs mimics changes seen in embryonic
development. Culture conditions and several factors that
FIG. 8. Cardiac differentiation potential of EBs derived
from different culture systems (STLV, SSC, and HD). (A)
Area of cTnT per EBs (· 105 lm2). (B) EBs were im-
munolabeled with cTnT (red) and counterstained with DAPI
(blue). Data are presented as mean– SEM of three indepen-
dent experiments. The difference was considered significant
when p < 0.05 (*), < 0.01 (**), < 0.0001 (****). Scale bars, 200lm.
Color images available online at www.liebertpub.com/cell
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partake necessary functions during early embryo develop-
ment are also expected to be involved in the formation of EBs
and cardiogenesis of EBs (Choi et al., 2005; Koike et al., 2007).
Recently, versatile bioreactor cultures have been increasingly
studied for stem cell expansion and differentiation; however,
much work remains to optimize large-scale, lineage-specific
differentiation for producing cardiac cells (Carpenedo et al.,
2007; Rungarunlert et al., 2009). In the first experiment, we
investigated the effect of varying dynamic culture parame-
ters and their influence on cardiac differentiation of ESCs. To
date, there is a limited amount of information that describes
the development of specific cell lineages within EBs (Des-
baillets et al., 2000). Also, the histological location of apo-
ptosis or proliferation, which plays important roles in the
early-stage embryonic development, has been rarely studied
within EBs. Our studies extend knowledge about cardiac
differentiation, especially in the context of histological
changes within EBs, such as apoptosis and cell proliferation.
Previously, we have demonstrated that EB production,
when seeding 3· 105 and 5· 105 cells/mL, is the most opti-
mal for inoculating STLV cultures to grow ESC-derived EBs
(Rungarunlert et al., 2011). Our initial experiment revealed
that STLV culture produced more EBs, which was homoge-
neous in size compared to HD-EBs. In addition, STLV-EBs
had a greater capacity to differentiate toward cardiac line-
ages than HD-EBs. For the first time, we describe the
FIG. 9. qRT-PCR analysis of STLV-, SSC-, and HD-derived EBs cultured with or without ASC supplement. (A) Oct-4, the
pluripotent marker. (B) Brachyury, mesodermal marker. (C) Nkx2.5, early cardiac marker. (D–F) Late cardiac markers Tnnt2
(D), Myh6 (E), and Myl2 (F). (G) AFP, endoderm marker.
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morphology of EBs, visualized by H&E staining on sections.
Co-labeling analysis for proliferation and apoptosis showed
that the STLV culture resulted in more uniform EBs with
similar inner and outer structures: (1) Highly proliferative
outer zone (edge) and (2) apoptotic center (cavity). This
mimics mouse embryo development at gastrulation stage
when a cavity forms in the embryo. Thus, STLV-EB cul-
ture conditions are more superior in quality than HD-EB
culture conditions.
Moreover, this is also the first report describing optimi-
zation of the time of STLV-EB adherence to gelatin-coated
dishes for improving the efficiency of cardiomyocyte differ-
entiation, similar to HD-EBs. We found that EBs plated
earlier (D2 and D3) are more capable of differentiation into
the cardiac lineage than EBs plated later (D4 and D5). This
may pinpoint an important time point for plating EBs on
adherent surfaces for even other alternate differentiation
studies. Staining of cleaved caspase-3 within all EBs marked
reduced cell viability and also a predisposition for cavitation,
which resembles the blastocyst stage of embryo development
(Fujita et al., 2008). When EBs were cultured long term, more
cells underwent programmed cell death. Hence, earlier EB
plating improved the efficiency of cells to spread out after EB
plating and differentiate into cardiac cells compared to EBs
plated later. Cavitation is the process in which cells undergo
both selective cell survival and programmed cell death in a
process that depends on signals from visceral endoderm in
the EBs (Desbaillets et al., 2000; Karbanova´ and Mokry,
2002). Our results showed that HD-EBs started to form small
cystic EBs on D4–D5, which preferentially differentiated into
the endoderm lineage. This is in agreement with our obser-
vations of a low efficiency of HD-EBs to differentiate into
cardiac cells, when plated later (D4 and D5). In standard
cardiac differentiation protocols using HD culture, the initial
cell seeding density is usually 400–1000 ESCs/mL, and the
EBs are usually plated on gelatin-coated dishes on D5 (Chen
et al., 2011; Kobolak et al., 2012; Mummery et al., 2002;
Passier and Mummery, 2005), resulting a general low effi-
ciency of cardiac differentiation. This may be due to the
mistiming in plating of the EBs onto gelatin. Hence, our re-
sults strongly indicate that plating EBs earlier, on day 3,
significantly improved the efficiency of cardiac differentia-
tion, which contained high numbers of proliferating cells that
preferentially formed cardiomyocytes.
In our second experiment, we found that the STLV culture
system provided a stable and ideal condition for mouse ESCs
to form high numbers of EB while retaining good quality and
subsequently were highly efficient at differentiating into car-
diomyocytes. EB formation using the STLV method was di-
rectly compared to the SSC and HD methods. Our results
further showed that 3 days postseeding of mouse ESCs using
the STLV culture system significantly improved the efficiency
of homogeneous EB production in mouse ESCs (approxima-
tely four times higher than SSC culture), similar to Lu¨ et al.
(2008). However, variations in the size of STLV-EBs derived
from human ESCs has been an unfavorable argument for use
of this technique. Interruptions to the stirring and micro-
gravity within the STLV, which can occur during changing of
the medium, could be a reason for agglomeration of EBs and
the formation of aggregates (Gerecht-Nir et al., 2004; Yirme
et al., 2008). Our results, however, confirmed that STLV cul-
ture is reproducibly beneficial for mouse ESCs to generate
high numbers of EBs, which retain quality as good as that
compared to other cultures, because this culture provides: (1)
Low fluid shear stress due to the horizontal whole-body ro-
tation, (2) a chamber without gas/fluid interfaces and bubbles
due to improved oxygen diffusion, (3) mild mixing of cells
due to a very low rotation speed, and (4) efficient gas ex-
change due to the high membrane area to volume of medium
ratio (Hammond and Hammond, 2001).
Furthermore, this is also the first report to describe that
STLV-EBs have the highest efficiency of spontaneous cardio-
myocyte differentiation over SSC-EBs and HD-EBs. We found
that HD-EBs had rhythmically contracting areas within EBs 1
day earlier than STLV-EBs and SSC-EBs. However, the overall
ability of HD-EB differentiation into cardiomyocytes was
lower, due to lower expression and distribution of cTnT. The
percentage of cardiac beating colonies/well was similar be-
tween the STLV-EBs and SSC-EBs. However, STLV-EBs
showed a higher efficiency of cardiac differentiation due to a
larger beating area and faster beating. Furthermore, the
measurement of cTnT area per EB showed that STLV-derived
EBs expressed cTnT three to five times higher than SSC- and
HD-derived EBs, regardless of the culture medium. This cor-
relates with a previous report, which described that approxi-
mately 30% of the nuclear transferred (NT)-EBs generated via
STLV contained vigorously contracting cells compared to 10%
of EBs generated via SSC (Lu¨ et al., 2008).
To determine the effect of ASC on inducing cardiac dif-
ferentiation, we investigated cardiac differentiation of mouse
EBs via different culture methods (STLV, SSC, and HD). We
initially induced the cells in the presence of ASC, followed by
plating and culture in defined medium. Our results showed
that ASC supplementation increased the area of cTnT ex-
pression per EB in all groups (1.9 times in STLV, 3.7 times in
SSC, and 2.3 times in HD group). Our results also confirmed
that ASC supplementation could induce cardiac differentia-
tion of ESCs at a similar rate to that described by Takahashi
et al. (2003). A previous report has also revealed that an
approximately three-fold improvement of NT-EB beating/
well could be generated via STLV when using ASC supple-
ment (Lu¨ et al., 2008).
The aim of our studies on EB formation and early EB
differentiation was to observe the germ layer’s organization
timing and patterns. Differences in EB mRNA and protein
expression patterns observed among different culture con-
ditions have been correlated with cardiac differentiation
potential. Our results showed a high level of Oct-4 in un-
differentiated cells that had diminished by D7, in agreement
with another report (Pekkanen-Mattila et al., 2010). Brachy-
ury is upregulated in the primitive streak and induces early
mesoderm formation (Pekkanen-Mattila et al., 2010); thus, is
was not surprising that its mRNA level was high from D3
until D7 and diminished later. The cardiac differentiation
assays detected a peak of Brachyury at D3–D4. In STLV-EBs
or SSC-EBs, our data indicated a gradual decrease, without
peaks, indicating the lack of cellular populations entering the
primitive streak stage; rather cells gradually differentiated
toward different directions, including cardiac. On the other
hand, Brachyury reached its peak around D3 in HD-EBs,
confirming observations described in earlier studies (Grai-
chen et al., 2008; Pekkanen-Mattila et al., 2010).
In parallel, many of the genes upregulated in EBs were
phenotypic markers of cardiac gene expression: Nkx2.5,
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Tnnt2, Myh6, and Myl2. Nkx2.5 gene expression, which
marks early cardiac precursors (Ranganayakulu et al., 1998;
Schwartz and Olson, 1999), peaked at D7 and stayed high
until D14. During mouse embryogenesis, Nkx2.5 is expressed
abundantly when the heart forms and in standard in vitro
differentiation assays peaks at D5–D8 (Akazawa and Komuro,
2005; Ma et al., 2008; Zhou et al., 2008). In our STLV groups,
the continuously high expression levels of Nkx2.5 indicate the
prolonged presence of cardiac precursor cells. Probably this is
due to the beneficial effect of STLV conditions improving the
viability of ESCs within the EBs. Interestingly, the expression
of Nkx2.5 increased when ASC was added on D7. Hence, our
results confirmed that ASC promotes cardiac differentiation
by inducing Nkx2.5, as described by Cao et al. (2012). Gra-
dually other cardiac markers, including those of cardiomyo-
cyte structural constituents such as Tnnt2, Myh6, and Myl2,
increased and peaked on D14. These observations are similar
to previous reports (Boheler et al., 2002).
Conclusions
This study has shown that methods of EB production and
the subsequent quality of EBs profoundly affected cardio-
genesis. An optimized STLV system allowed a superior
control of cellular agglomeration forming homogeneous
sized EBs, improving further proliferation and finally cardiac
differentiation of ES cells. Therefore, the STLV method could
provide a positive impact on applications, including disease
modeling, drug screening, and regenerative medicine.
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